Shanghai SIMR Biotechnology Co., Ltd.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Shanghai SIMR Biotechnology Co., Ltd.
Leading the group were Trinomab Biotech, which develops antibodies for infectious diseases, and cell and gene developers BRL Medicine and XellSmart.
Two IPOs and 12 venture capital and private equity deals in China raised a combined $1bn in a hectic few weeks of October.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.